FDA inspection
Repro Lab, Inc.: FDA inspection ending Nov 19, 2024
FDA inspection 1255573 · Voluntary Action Indicated (VAI) · New York, NY
Key facts
| Inspection ID | 1255573 |
|---|---|
| Firm | Repro Lab, Inc. |
| FEI number | 3000974212 |
| Address | 332 E 30th St |
| City | New York |
| State | NY |
| ZIP | 10016 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Nov 19, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data